Orna Therapeutics Stock

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

Sign up today and learn more about Orna Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Orna Therapeutics Stock

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.

Funding History

January 2020$20.0M
February 2021$80.0M
August 2022$221M

Management

Founder & Director, Molecular Biology

Alex Wesselhoeft

Founder, Director of Business Development & Former Board Director

Raffaella Squilloni

Chief Executive Officer

Thomas M. Barnes

Founder

Daniel Anderson

Chief Legal and Strategy Officer

Nishla Keiser

Chief Financial Officer

John McCabe

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo